Delivery Order SPE2DB20D3103-SPE2DB25FM2H9
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,732,286 units of Cyclophosphamide 2 GM vials, a chemotherapy drug. The $70,284.14 firm-fixed-price contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $1,068.20 firm-fixed-price contract is for the supply of Cyclophosphamide 1 GM vials, with a completion date of September 4, 2024. The contract is not set aside.
Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,735.80 contract is for the delivery of Cyclophosphamide 500 mg vials, a critical pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,465.36 contract is for the supply of 4,566,433,889 units of Cyclophosphamide 2 gm vials, a critical cancer treatment medication. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,118,918 units of the pharmaceutical product Cyclophosphamide 1 GM/5 ML VL 5ML. The order, valued at $1,449.08, has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,155.52, is for the delivery of Cyclophosphamide 2 GM/10 ML VL 10ML, a chemotherapy medication, to support military healthcare programs. The contract has an ultimate completion date of December 31, 2024. This award is a delivery order under a larger Indefinite Delivery Contract...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $77,013.02 firm fixed price contract is for the supply of 4,565,682,849 vials of the chemotherapy drug cyclophosphamide. The award is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025 that provides a comprehensive range of medical commodities to support military treatment programs...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to the Defense Logistics Agency (DLA). The $9,120.41 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 9, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of 4,563,881,075 units of Cyclophosphamide 500 mg vials with a potential value of $2,158.88. The contract has a completion date of March 7, 2024 and was awarded on March 6, 2024.
Amerisourcebergen Drug Corp holds an indefinite delivery...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to support healthcare programs administered by the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with a ceiling value of $10,761.60 and a completion date of September 1, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open...